vs
Dover Corporation（DOV）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
Dover Corporation的季度营收约是瑞思迈的1.5倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs 13.4%，领先14.2%），Dover Corporation同比增速更快（12.5% vs 11.0%），过去两年瑞思迈的营收复合增速更高（7.9% vs -1.8%）
美国工业产品综合性制造集团，1955年成立，总部位于伊利诺伊州唐纳斯格罗夫。旗下业务分为工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术五大板块，为标普500指数成分股，纽交所交易代码DOV，2024年位列财富榜单第448位。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
DOV vs RMD — 直观对比
营收规模更大
DOV
是对方的1.5倍
$1.4B
营收增速更快
DOV
高出1.5%
11.0%
净利率更高
RMD
高出14.2%
13.4%
两年增速更快
RMD
近两年复合增速
-1.8%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $1.4B |
| 净利润 | $282.1M | $392.6M |
| 毛利率 | 39.1% | 61.8% |
| 营业利润率 | 16.5% | 34.6% |
| 净利率 | 13.4% | 27.6% |
| 营收同比 | 12.5% | 11.0% |
| 净利润同比 | 22.2% | 13.9% |
| 每股收益（稀释后） | $2.06 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOVRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.1B | $1.3B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $2.0B | $1.2B |
净利润DOVRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | $282.1M | — | ||
| Q4 25 | $282.1M | $392.6M | ||
| Q3 25 | $302.0M | $348.5M | ||
| Q2 25 | $279.1M | $379.7M | ||
| Q1 25 | $230.8M | $365.0M | ||
| Q4 24 | $1.4B | $344.6M | ||
| Q3 24 | $347.1M | $311.4M |
毛利率DOVRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | 39.1% | — | ||
| Q4 25 | 39.1% | 61.8% | ||
| Q3 25 | 40.1% | 61.5% | ||
| Q2 25 | 39.9% | 60.8% | ||
| Q1 25 | 40.0% | 59.3% | ||
| Q4 24 | 41.4% | 58.6% | ||
| Q3 24 | 38.5% | 58.6% |
营业利润率DOVRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | 16.5% | — | ||
| Q4 25 | 16.5% | 34.6% | ||
| Q3 25 | 18.2% | 33.4% | ||
| Q2 25 | 17.3% | 33.7% | ||
| Q1 25 | 15.9% | 33.0% | ||
| Q4 24 | 14.0% | 32.5% | ||
| Q3 24 | 16.8% | 31.6% |
净利率DOVRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | 13.4% | — | ||
| Q4 25 | 13.4% | 27.6% | ||
| Q3 25 | 14.5% | 26.1% | ||
| Q2 25 | 13.6% | 28.2% | ||
| Q1 25 | 12.4% | 28.3% | ||
| Q4 24 | 96.4% | 26.9% | ||
| Q3 24 | 17.5% | 25.4% |
每股收益（稀释后）DOVRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | $2.06 | — | ||
| Q4 25 | $2.06 | $2.68 | ||
| Q3 25 | $2.19 | $2.37 | ||
| Q2 25 | $2.02 | $2.58 | ||
| Q1 25 | $1.67 | $2.48 | ||
| Q4 24 | $10.38 | $2.34 | ||
| Q3 24 | $2.51 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $3.3B | $663.8M |
| 股东权益账面价值 | $7.4B | $6.3B |
| 总资产 | $13.4B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资DOVRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M |
总债务DOVRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | $3.3B | — | ||
| Q4 25 | $3.3B | $403.9M | ||
| Q3 25 | $3.1B | $408.7M | ||
| Q2 25 | $3.1B | $658.4M | ||
| Q1 25 | $3.0B | $663.1M | ||
| Q4 24 | $2.9B | $662.9M | ||
| Q3 24 | $3.0B | $667.6M |
股东权益DOVRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | $7.4B | — | ||
| Q4 25 | $7.4B | $6.3B | ||
| Q3 25 | $7.7B | $6.1B | ||
| Q2 25 | $7.4B | $6.0B | ||
| Q1 25 | $7.1B | $5.5B | ||
| Q4 24 | $7.0B | $5.3B | ||
| Q3 24 | $5.7B | $5.2B |
总资产DOVRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | $13.4B | — | ||
| Q4 25 | $13.4B | $8.5B | ||
| Q3 25 | $13.4B | $8.3B | ||
| Q2 25 | $13.2B | $8.2B | ||
| Q1 25 | $12.6B | $7.6B | ||
| Q4 24 | $12.5B | $7.1B | ||
| Q3 24 | $11.9B | $7.2B |
负债/权益比DOVRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.45× | 0.06× | ||
| Q3 25 | 0.40× | 0.07× | ||
| Q2 25 | 0.41× | 0.11× | ||
| Q1 25 | 0.42× | 0.12× | ||
| Q4 24 | 0.42× | 0.13× | ||
| Q3 24 | 0.53× | 0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
